These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38586882)

  • 41. The potential of some functional group compounds substituted 8-Manzamine A as RSK1 inhibitors: molecular docking and molecular dynamics simulations.
    Zayed AOH; Altarabeen M; AlShamaileh E; Zain SM
    J Biomol Struct Dyn; 2024 Feb; ():1-10. PubMed ID: 38319051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Antimycobacterial Agent Using In Silico Virtual Screening, ADME Prediction, Docking, and Molecular Dynamics Simulations Approach.
    Tripathy S; Sahu SK; Azam MA; Jupudi S; Gupta VK; Sharma S
    Curr Comput Aided Drug Des; 2021; 17(6):806-816. PubMed ID: 32748754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors.
    Rathi E; Kumar A; Kini SG
    J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Chun CY; Khor SXY; Chia AYY; Tang YQ
    Int J Health Sci (Qassim); 2023; 17(3):3-10. PubMed ID: 37151745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
    Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
    J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations.
    Halder D; Das S; Jeyaprakash RS
    Mol Divers; 2023 Sep; ():. PubMed ID: 37715109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking.
    Karpiński TM; Ożarowski M; Silva PJ; Stasiewicz M; Alam R; Samad A
    Pathogens; 2023 Jun; 12(6):. PubMed ID: 37375532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC-MS/LC-MS characterization, molecular docking and molecular dynamics simulation.
    Das SK; Mahanta S; Tanti B; Tag H; Hui PK
    Mol Divers; 2022 Feb; 26(1):365-388. PubMed ID: 33961167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computational identification of natural product inhibitors against EGFR double mutant (T790M/L858R) by integrating ADMET, machine learning, molecular docking and a dynamics approach.
    Agarwal SM; Nandekar P; Saini R
    RSC Adv; 2022 Jun; 12(26):16779-16789. PubMed ID: 35754875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.
    Pokhrel S; Bouback TA; Samad A; Nur SM; Alam R; Abdullah-Al-Mamun M; Nain Z; Imon RR; Talukder MEK; Tareq MMI; Hossen MS; Karpiński TM; Ahammad F; Qadri I; Rahman MS
    Int J Biol Macromol; 2021 Nov; 191():1114-1125. PubMed ID: 34592225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Selective Inhibitors of
    Sharma VK; Bharatam PV
    J Comput Biol; 2021 Jan; 28(1):43-59. PubMed ID: 32207987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach.
    Imran M; Abida ; Alotaibi NM; Thabet HK; Alruwaili JA; Asdaq SMB; Eltaib L; Kamal M; Alshammari ABH; Alshammari AMA; Alshehri A
    J Infect Public Health; 2023 Apr; 16(4):554-572. PubMed ID: 36812878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
    Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploration of Novel Lichen Compounds as Inhibitors of SARS-CoV-2 Mpro: Ligand-Based Design, Molecular Dynamics, and ADMET Analyses.
    Gupta A; Sahu N; Singh AP; Singh VK; Singh SC; Upadhye VJ; Mathew AT; Kumar R; Sinha RP
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6386-6406. PubMed ID: 35921031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-guided computational insecticide discovery targeting
    Tahir A; Siddiqi AR; Maryam A; Chaitanya Vedithi S; Blundell TL
    J Biomol Struct Dyn; 2023 Oct; ():1-14. PubMed ID: 37814544
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacophore model-aided virtual screening combined with comparative molecular docking and molecular dynamics for identification of marine natural products as SARS-CoV-2 papain-like protease inhibitors.
    Thangavel N; Albratty M
    Arab J Chem; 2022 Dec; 15(12):104334. PubMed ID: 36246784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
    Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
    J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.